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Antibodies are indispensable reagents in basic research, and those raised against tags constitute a useful tool for the evaluation
of the biochemistry and biology of novel proteins. In this paper, we describe the isolation and characterization of a single-
domain recombinant antibody (VHH) speciﬁc for the SNAP-tag, using Twist2 as a test-protein. The antibody was eﬃcient in
western blot, immunoprecipitation, immunopuriﬁcation, and immunoﬂuorescence. The sequence corresponding to the anti-
SNAP has been subcloned for large-scale expression in vectors that allow its fusion to either a 6xHis-tag or the Fc domain of rabbit
IgG2 taking advantage of a new plasmid that was speciﬁcally designed for VHH antibodies. The two diﬀerent fusion antibodies
were compared in immunopuriﬁcation and immunoﬂuorescence experiments, and the recombinant protein SNAP-Twist2 was
accurately identiﬁed by the anti-SNAP Fc-VHH construct in the nuclear/nucleolar subcellular compartment. Furthermore, such
localization was conﬁrmed by direct Twist2 identiﬁcation by means of anti-Twisit2 VHH antibodies recovered after panning of
the same na¨ ıve phage display library used to isolate the anti-SNAP binders. Our successful localization of Twist2 protein using the
SNAP-tag-based approach and the anti-Twist2-speciﬁc recombinant single-domain antibodies opens new research possibilities in
this ﬁeld.
1.Introduction
Several reasons contributed to the remarkable success of the
technology based on the SNAP-stag among other methods
conceived for protein labeling [1, 2]. The SNAP-tag is
derived from the human O6-alkylguanine-DNA alkyltrans-
ferase involved in DNA repair and allows, both in vitro
and in vivo,a ne ﬃcient and rapid covalent labeling of
proteins fused to SNAP-tag with any molecule possessing
an O(6)-benzylguanine (BG) group. In contrast to labeling
strategies based on reactive amino groups or cysteines, this
reaction generates labeling at a deﬁned site and with 1:1
stoichiometry. A large variety of common reagents used in
biology and biotechnology applications are already available,
and both proteins and antibodies have been successfully
covalently conjugated with ﬂuorochromes, PEG, biotin,
drugs, and other suitable molecules [1–14].
However, despite its reliability, the method has been
designed for exclusive single tagging and is not suitable
for applications, such as correlative microscopy, in which
double labeling is mandatory. Furthermore, it may be
useful to pair other applications, such as staining with
pull-down or PEG-binding and in vivo imaging. A speciﬁc
antibody raised against SNAP would allow a second and
independent labeling of polypeptides fused to SNAP-tag.
However, only polyclonal anti-SNAP antibodies are available
so far, although these reagents do not guarantee data repro-
ducibilitywhendiﬀerentbatchesareused.Furthermore,full-
size antibodies may be too bulky for some applications such
as in vivo tissue penetration [15]. Therefore, we decided to2 Journal of Biomedicine and Biotechnology
select and characterize anti-SNAP monoclonal recombinant
antibodies in VHH format by panning the llama na¨ ıve
library previously described in [16]. Isolated antibodies were
expressed using vectors that enabled the fusion to diﬀerent
tags and the eﬃciency of these constructs was analyzed in the
conventional immunotechniques.
2.MaterialandMethods
2.1.Panning,Identiﬁcation,andProductionofAnti-SNAPand
Anti-Twist2 VHH Antibodies, and Protein-Protein Interaction
Assays. The phage repertoire was panned using Maxisorp
immunotubes (Nunc) coated with GST, GST-SNAP, and
GST-Twist2 according to the protocol described in [16].
Twist2 was chosen based on the paucity of reliable antibodies
for investigating the biology of this nuclear transcription
factor [17]. A preliminary depletion panning step was
performed in the presence of GST to eliminate the binders
with speciﬁcity for the fusion carrier.
For each antigen, ninety-six single colonies from both
the second and third panning steps were grown 4 hours
at 37
◦C in 2xTY supplemented with 0.1mg/mL ampicillin,
0.1% glucose, induced with 1mM IPTG, and incubated
overnight at 30
◦C. Cultures were harvested; the periplasmic
fractions containing the soluble HA-tagged VHHs were
diluted 1:3 and incubated with mouse supernatant anti-HA
(10μg/mL)foruseinELISA.Maxisorp96-wellplates(Nunc)
were coated at the concentration of 100ng/well with either
GST alone or the fusion constructs overnight in 50mM
sodium carbonate buﬀer at 4◦C. After standard blocking
and washing steps, the color reaction was developed by
the addition of ABTS, and the absorbance at 405nm was
measured after 30min. Clones having an absorbance value
at least four times higher than the background and showing
no aﬃnity for the fusion tag GST were considered positive
and sequenced to identify unique binders. Such clones were
subcloned into the pHEN6 vector [16] and transformed into
XL1Blue competent cells to obtain His-tagged recombinant
VHH binders. Bacteria were grown at 28
◦C in Terriﬁc Broth
supplemented with 0.1% glucose, 0.1mg/mL ampicillin, and
0.01mg/mL tetracycline till the optical density at 600nm
reached the value of 0.6. Recombinant expression was
induced with 1 mM IPTG, and the bacteria were harvested
after 16 hours. The periplasmic fraction [16]w a sp u r i ﬁ e d
by aﬃnity chromatography using a HiTrap HP chelating
column and an ¨ AKTA FPLC Explorer (GE Healthcare).
For GST pull-down experiments, SNAP-Twist2 was in
vitrotranslated (IVT) with [ 35S]-methionine (Perkin Elmer)
using the TNT System (Promega). IVT-Twist2 was incubated
together with 3μg of recombinant GST-Twist1, GST-Twist2,
or GST in binding buﬀer (20mM Tris-Cl, pH 8.0, 150mM
NaCl, 5mM MgCl2, 0.2mM EDTA, and 0.1% Nonidet-P40)
plus 30μL of Glutathione-Sepharose Resin (GE Healthcare).
The resin was incubated for 2 hours at 4◦C and then
extensively washed. Bound proteins were separated by SDS-
PAGE and the gels were stained with Coomassie Brilliant
Blue, dried, and exposed to X-ray ﬁlms (Kodak) to identify
the radioactive SNAP-Twist2 fusion protein.
2.2. Preparation of the pFuseVHH Vectors and VHH-Fc
Antibody Production. The pFUSE-xFc2-adapt-scFv plasmids
[18] were modiﬁed to allow the direct inframe cloning of
VHH sequences from pHEN4. The vectors were digested
with NcoI and BglII, and the PCR product was obtained
using the primers 5 ATCGGCCATGGCTGAGGTGCAGC-
TG3  (Fw, NcoI recognition sequence in bold), and 5 GGA-
GGAGATCTGCGGCCGCTGGAGA3  (Rev, BgIII and NotI
sequences in bold), and the sequence of the 2C1 VHH as a
template was ﬁrst digested with the same restriction enzymes
and ﬁnally ligated. The original VHH sequence was cut
out using the restriction sites NcoI-NotI and substituted
with a staﬀer (GST-sequence). Its presence was used to
evaluate the quality of the vector digestion and simplify
the discrimination between self-ligated clones and clones in
which VHH sequences were correctly subcloned from other
vectors. The resulting constructs were fusion sequences of
VHHs and Fc domains of human, mouse, or rabbit origin.
HEK293T cells at 90% conﬂuence were transfected
with 20μg/plate of the modiﬁed vectors using calcium
phosphate protocol and grown in Dulbecco’s Modiﬁed Eagle
Medium (DMEM) plus 10% FBS, 1% L-glutamine, 1%
PS-5 antibiotic, 1% Na pyruvate 1% nonessential amino
acids. The medium was renewed 24 hours after transfection
and substituted 48 hours after transfection by serum-free
medium. It was ﬁnally collected 96 hours after transfection,
andFc-VHHantibodieswereaﬃnitypuriﬁedusingaprotein
A column (GE Healthcare).
2.3. Western Blot and Immunoprecipitation. Fractions corre-
sponding to puriﬁed recombinant GST-SNAP (10–100ng)
or GST-SNAP overexpressed in bacterial total lysate (10μL)
were separated in 15% SDS-PAGE and transferred to a nitro-
cellulose membrane. Blots were blocked with 5% skimmed
milk in PBS and incubated with VHH periplasmic extract
diluted 1:3 and 10μg/mL of anti-HA monoclonal antibody.
The membranes were ﬁnally washed in PBS plus 0.1% Tween
(PBST), and the speciﬁc signal was detected by incubation
with HRP-conjugated anti mouse.
Biotinylated VHH anti-SNAP antibodies (0.5–1μg) were
incubated in the presence of recombinant GST-SNAP (0.1–
0.5μg), and the immune complex was precipitated after 1
hour incubation with 50μL of avidin beads (Pierce). Beads
were washed four times with PBST and boiled in 2x Laemmli
sample buﬀer before SDS-PAGE.
The anti-SNAP VHH 3G1B-Fc(rabbit) was incubated for
2 hours at room temperature with the lysates recovered from
SNAP-Twist2-transfected and control HeLa cells. Protein A
beads (50μL) were added to the immune complex. After 1
hour incubation, beads were washed four times with PBST
a n db o i l e di n2 xL a e m m l is a m p l eb u ﬀer before SDS-PAGE.
2.4. Immunopuriﬁcation. Three diﬀerent constructs were
compared: VHH 3G1B-Fc(rabbit), VHH 3G1B-6xHis, and
llama polyclonal antibodies. One- and-half mg of aﬃnity-
puriﬁedantibodiesagainstSNAPwasusedtocross-link1mL
of AminoLink coupling gel according to the manufacturer’s
instructions (Pierce). Antibody coupling to the resin wasJournal of Biomedicine and Biotechnology 3
checked by analyzing few microliter of each sample by
SDS-PAGE, and the three samples were loaded onto empty
columns to drain out the buﬀer. Resins were washed with
20mL of 1M NaCl before equilibrating the columns with
20mL of PBS. Each column was loaded with 15mL of lysate
recovered from bacteria over expressing the SNAP-Twist2
construct, incubated 1 hour by gentle end-over-end rocking
and washed with 30 mL of PBS. Protein samples were eluted
by applying 4mL of glycine buﬀer (100mM, pH 3.0) and
immediately neutralized by the addition of 100μLo f1 M
Tris-HCl, pH 8.5.
2.5. Immunoﬂuorescence. 106 HeLa cells were seeded in
15cm2 plates before being transfected with 20μg of plasmid
DNA coding for the SNAP-Twist2 construct, using the
calcium phosphate transfection method. Transfected HeLa
cells were seeded on coverslips coated with 0.5mL of 0.1%
gelatin solution and the day after labeled using SNAP-Cell
TMR-Star (NEB) according to manufacturer’s instructions.
Slides were rinsed three times with PBS, and cells were
ﬁxed with 4% formaldehyde in PBS for 15min, permeabi-
lized with 0.5% Triton X-100 for 5min, washed three times,
and blocked with 2% BSA. Successively, cells were incubated
for 1 hour at 37
◦C in the presence of 5μg/mL of puriﬁed
anti-SNAP VHH 3G1B-Fc(rabbit), washed three times and
incubated with FITC-conjugated (1:50) secondary anti
rabbit antibodies. Finally, slides were incubated 3min with
DAPI, mounted, and assessed by ﬂuorescence microscopy at
the DAPI, GFP, and Cy3 channels.
When the HA-tagged VHH anti-Twist2 antibodies were
used, the cells were incubated for 1 hour at 37
◦C in the
presence of the periplasmic VHH fraction and of the mouse
monoclonal anti-HA antibody, washed three times, and
incubated with a secondary FITC-conjugated (1:50) anti
mouse antibody.
3. Results
Puriﬁed recombinant proteins GST-SNAP and GST-Twist2
have been used to isolate single-domain antibodies by
panning against a large llama na¨ ıve library according to
the previously described protocol in [16]. The speciﬁcity
of the isolated clones was evaluated by ELISA, and the
most reactive antibodies were considered for further char-
acterization. Sequencing results indicated the presence of
two independent anti-SNAP (3C4B and 3G1B) and three
diﬀerent anti-Twist2 (2C12, 2D11, 3E1) clones. The latter
were intended primarily for immunoﬂuorescence applica-
tions and, therefore, were produced as HA-tagged VHHs.
For simplifying their large-scale puriﬁcation, the anti-SNAP
VHHs were initially subcloned to obtain 6xHis-tagged
recombinant antibodies and their reliability was tested in the
standard immunotechniques.
VHH antibodies preferentially recognize epitopes such
as cavities and grooves that can be lost when the antigen is
unfolded. For this reason, they are not the reagents of choice
for WB. However, both 3C4B and 3G1B clearly recognized
10ng of puriﬁed GST-SNAP protein (Figure 1(a)) and the
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Figure 1: Application of anti-SNAP antibodies in western blot
experiments. (a) Detection of 100 and 10ng of blotted puriﬁed
recombinant GST-SNAP protein by means of the VHH antibodies
3C4B and 3G1B. (b) Detection of overexpressed GST-SNAP
in bacterial total lysates using the same VHH antibodies. The
secondaryantibodyanti-llamaimmunoglobulinsusedfordetection
recognized nonspeciﬁcally a further band of 32kDa.
same recombinant protein was present in a total bacterial
lysate (Figure 1(b)). These preliminary results indicated that
the selected anti-SNAP VHHs could be used for identifying
by WB targets that are overexpressed recombinant proteins.
The secondary anti-llama polyclonal antibodies rec-
ognized a bacterial protein nonspeciﬁcally (Figure 1(b)).
Therefore, we decided to exploit the opportunity of manip-
ulating recombinant material for designing a new expression
vector that would allow overcoming this drawback. Con-
sequently, a new plasmid (pFuseVHH) was developed that
enables the fusion of the VHH sequence to a Fc domain
(see Figure S1 in supplementary material available conﬁne at
doi:10.1155/2010/658954). Itisbasedonaplasmidoriginally
conceived for the eﬃcient production of scFvs [18] and that
provides a Fc domain for aﬃnity puriﬁcation with yields
comparable to those of the His-tag. However, Fc domain is
a signiﬁcantly better target for secondary antibodies (and
labeled Protein A) and increases the antibody avidity by
dimerization.
The anti-SNAP VHH that gave the highest signal in WB
(3G1B) was subcloned in the pFuseVHH plasmid (with rab-
bit Fc), and both His-tagged and Fc-tagged 3G1B antibodies
were tested for immunoprecipitation experiments.
The immunoprecipitation feasibility was ﬁrst conﬁrmed
using puriﬁed GST-SNAP protein and biotinylated puriﬁed
His-tagged 3G1B (Figure 2(a)). Successively, the 3G1B-
Fc(rabbit) construct was used in combination with total
lysate from mammalian cells transfected with SNAP-Twist2.
The recombinant antibody was able to completely deplete
the target protein from the solution, as clearly showed in
Figure 2(b).
We next compared the potentiality of the two 3G1B
constructs (His- and Fc-tagged) and that of a polyclonal
antibody for immunopurifying recombinant SNAP-Twist2-
protein from large volumes. The antibodies were covalently
bound to sepharose beads and packed into columns. The
eﬀective binding between antibodies and beads was veriﬁed4 Journal of Biomedicine and Biotechnology
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Figure 2: Application of anti-SNAP antibodies in immunopuriﬁ-
cation experiments. (a) Puriﬁed GST-SNAP (0.5 or 0.1μg) were
incubatedinthepresenceofthebiotinylatedanti-SNAPVHH3G1B
(5 or 1μg), and the antigen-antibody complex was precipitated
usingavidinbeads.TheproteinswereseparatedbySDS-PAGE,blot-
ted, and ﬁnally detected using either anti-GST (upper membrane
strip) or anti-VHH speciﬁc antibodies (lower membrane strip).
Biotinylated VHHs were incubated in the presence of avidin beads
and in the absence of GST-SNAP as a control of the pull-down
eﬃciency. (b) Lysates from mammalian HEK293T cells transiently
t r a n s f e c t e dw i t h2 0 μg/plate plasmid for expressing the SNAP-
Twist2 fusion construct were incubated with the anti-SNAP 3G1B-
Fc(R) antibody, and the antigen-antibody complex was precipitated
by means of Protein A.
by analyzing the washing fractions and by boiling a small
bead sample for each experimental condition (Figure 3). The
target protein was successfully puriﬁed from the total lysate
by using all three conﬁgurations, although a certain yield
diﬀerence was observed (Figure 3).
Finally, we designed an immunoﬂuorescence experiment
to show that anti-SNAP antibodies could be used for double
tagging of a target protein fused to SNAP-tag. Cultured HeLa
cells were transfected with a plasmid for the expression of
SNAP-Twist2 and the recombinant protein was identiﬁed
either by using the membrane-permeable SNAP-Cell TMR
Star ﬂuorochrome that directly reacts with the tag or using
the 3G1B-Fc(rabbit) recombinant antibody in combination
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Figure 3: Comparison of the protein yields obtained by immunop-
uriﬁcation using diﬀerent antibody formats. The protein SNAP-
Twist2 was immunopuriﬁed from total lysate using sepharose
columns to which the following antibodies were covalently linked:
llama IgG anti-SNAP polyclonal antibodies; 6xHis tagged llama
recombinant antibody 3G1B in VHH format; the same 3G1B
antibody fused to the rabbit Fc domain.
with an anti-rabbit FITC secondary antibody. The attempt
of using His-tagged 3G1B in immunoﬂuorescence was
abandoned due to the poor quality of anti-His secondary
antibodiesavailableforthistechnique.Thenuclear/nucleolar
subcellular localization of both SNAP signals, namely the
one identiﬁed by the ﬂuorochrome covalently bound to
the active SNAP site and the other due to the anti-SNAP
antibody recognition, is clearly showed in Figures 4(a)–
4(d). No signiﬁcant background was detected in nontrans-
fected control cells, excluding the possibility that native
O6-alkylguanine-DNA alkyltransferase may interfere with
the signal of recombinantly expressed SNAP-fused proteins
(Figure 4(i)). Similarly, the anti-SNAP 3GB1 did not recog-
nize endogenous O6-alkylguanine-DNA alkyltransferase in
CHO (hamster) and NIH (mouse) cells (data not shown).
GST pull-down experiments using the SNAP-Twist2 IVT
protein demonstrate that the SNAP-tag does not aﬀect the
ability of Twist2 to form homo-(not shown) or heterodimers
with GST-Twist1 (Figure S2). No nonspeciﬁc binding was
detected in the presence of GST-only recombinant protein.
The nuclear localization inferred by the two SNAP
detection methods is in agreement with the reports con-
cerning the physiological role of Twist2 [19, 20]a n dw a s
further conﬁrmed by the direct protein labeling by means
of the speciﬁc anti-Twist2 VHH antibody 2C12 (Figures
4(e)–4(h)). Interestingly, although the anti-Twist2 antibody
2C12 does not detect endogenous Twist2 in the cell nucleus
(Figure 4(j)), it seems that another anti-Twist2 candidate
(3E1) can identify it (Figure 4(k) and Figure S3). Epsin 8 is a
protein interacting with actin [21], and the construct SNAP-
Epsin8 correctly accumulated in the cytoplasm (Figure 4(l)).
ThiscontrolexperimentrulesoutaSNAP-dependentnuclear
localization.Journal of Biomedicine and Biotechnology 5
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Figure 4: Double staining of SNAP-tagged Twist2 obtained by coupling speciﬁc antibodies and benzylguanine-ﬂuorochromes. HeLa cells
were transiently transfected using 20μg/plate of plasmid for the expression of the SNAP-Twist2 protein. Its subcellular localization was
identiﬁed: (a) and (e) by the in vivo addition of the permeable SNAP-Cell TMR Star ﬂuorochrome (dilution 1:200); (b) by means of the
puriﬁed recombinant anti-SNAP antibody 3G1B fused to the rabbit Fc (5μg/mL); (f)by means of the cell culture supernatant containing the
recombinantanti-Twist2VHHantibody2C12(dilution1:2);(d)and(h)arethemergedimagesof(a)+(b)and(e)+(f),respectively;(c)and
(g) correspond to the nuclear DAPI staining; (i), (j), and (k) are nontransfected cells (controls) treated with the indicated antibodies. HeLa
cells transfected with SNAP-Epsin8 were stained with SNAP-Cell TMR Star ﬂuorochrome (dilution 1:200) to rule out a SNAP-dependent
nuclear staining (l).
4. Discussion
Highqualityreagentsarecrucialforobtainingreliableresults
in basic research and diagnostics. Monoclonal antibodies
are preferred since their reproducibility does not depend on
individual response, as in the case of polyclonal antibodies,
and their availability assures the possibility of comparing
data from diﬀerent laboratories. This is, for instance, the
case of antibodies directed against tags since these can be
linked to a large variety of proteins and matrixes under
diﬀerent experimental conditions [22]. The SNAP-tag not
only enables the covalent binding of any molecule with a BG
group, but its further detection also by means of an antibody
would allow a double tagging of the SNAP and its fusion
partners, a favorable condition, for instance, for correlative
microscopy applications.
We chose the selection of a monoclonal recombinant
antibody in VHH format because of the high stability,
elevated yields, and small dimension of this antibody class
as well as the possibility to manipulate the construct
using standard molecular biology techniques [15]. It was,
therefore, possible to evaluate three diﬀerent tags fused to
VHHs (6xHis, HA, and Fc). His-tag allows the straight-
forward aﬃnity puriﬁcation of the linked antibody, and,
probably because of its low molecular mass, the His-VHH
was the most suitable format for preparing aﬃnity column
for large-scale immunopuriﬁcation (Figure 3). However, it
is common experience that His-tag constitutes a poor
target for secondary antibodies and for this reason, it is
not normally utilized in immunofuorescence applications.
Therefore, we designed a new vector for Fc-fusion of the
VHH antibodies. Fc-domain is compatible for Protein A-
based aﬃnity puriﬁcation, and since it induces dimerization,
it has a higher avidity with respect to monomeric constructs.
We ﬁrst showed the reliability of the Fc-VHH construct
in immunoprecipitation assay. It should be underlined that
any single-domain antibody has the advantage over the
conventional IgGs of giving a single signal (heavy chain)
instead of two (heavy and light chains) in blot detection
(Figure 2(b)). Furthermore, VHHs can be fused to three6 Journal of Biomedicine and Biotechnology
diﬀerent Fc domains (human, mouse, and rabbit) that can
be chosen accurately to avoid background signals caused, for
instance by using mouse monoclonal antibodies on murine
cells. As an example, we successfully used the rabbit Fc-VHH
immunoﬂuorescence analysis in human cells (Figure 4).
More speciﬁcally, we deﬁned the SNAP-Twist2 subcel-
lular localization using three diﬀerent labeling approaches.
The recombinant protein was very clearly identiﬁed in
nucleus/nucleoli using: (a) a permeable ﬂuorochrome spe-
ciﬁc for SNAP; (b) the anti-SNAP Fc-VHH; (c) an anti-
Twist2 VHH antibody. The data obtained with transfected
cells seem to be conﬁrmed by staining wild-type cells
with another anti-Twist2 VHH antibody that apparently
recognizes the endogenous protein. This achievement is
remarkable since so far there was only a single report of
Twist2 immunoﬂuorescence staining using an anti-Twist2
antibody on transfected cells [20]. However, the signal was
quite blurred and the manufacturer (Abcam) does not
indicate in the attached data sheet that the commercial
antibody is suitable for immunoﬂuorescence. It would be
interesting to understand if the lack of the light chain confers
to VHHs a broader recognition capacity among slightly
modiﬁed structures of the same antigens, such as the Twist2
expressed in human cells and as a recombinant protein in a
prokaryotic system.
5. Conclusions
An anti-SNAP VHH recombinant antibody was isolated,
extensively characterized according to the most recent
recommendations [23], and it was subcloned in a new
vector that enables the production of Fc-fusions. The
antibodywassuitableforallthestandardimmunotechniques
and, alone or in combination with direct SNAP labeling,
allowed the immunoﬂuorescence localization of Twist2. The
nuclear/nucleolar localization of this protein was further
conﬁrmed by using speciﬁc anti-Twist2 VHH antibodies.
This is in agreement with the only previous immunoﬂuores-
cencereport, but the resolution obtained with the VHHs and
SNAP system was signiﬁcantly higher.
Finally, the availability of a reliable anti-SNAP antibody
thatcanbefusedtoanysuitabletagintroducesthepossibility
of double tagging the proteins fused to SNAP since the
residue for covalent binding of this tag remains available for
reacting with any BG-conjugated molecule. This option can
be used, for instance, to couple immunodetection to pull-
down experiments, but we expect that it will be particularly
beneﬁcial in correlative microscopy, a technique in which
both ﬂuorescent and gold probes may be detected. The small
dimension of the VHH antibodies should confer a further
advantage in terms of image resolution.
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